Education
About Us
Working with TipRanks
Follow Us
Daily Stock Ratings & Price Targets
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY | ― | 12.60% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $108 | ― | 13.10% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $30 | ― | 13.10% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY | ― | 10.20% | Reiterated | ||||
 | Exelixis | BUY | ― | -6.40% | Reiterated | Truist Financial Remains a Buy on Exelixis (EXEL) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY | ― | 4.00% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $156→$134 | ― | 3.30% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $118→$120 | ― | 3.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $150→$162 | ― | 18.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $65→$70 | ― | 14.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $33 | ― | 12.10% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $40 | ― | 30.40% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $260 | ― | 30.40% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $260 | ― | 13.90% | Initiated | ||||
| Winnebago Industries | BUY $42 | ― | -23.00% | Reiterated | Analysts Offer Insights on Consumer Cyclical Companies: Winnebago Industries (NYSE: WGO) and MTY Food Group (Other OTC: MTYFF) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD | ― | 7.50% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $14 | ― | 12.10% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $62 | ― | 12.10% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $28 | ― | 5.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $100 | ― | 18.80% | Reiterated | ||||
| Domino's Pizza | BUY $540 | ― | -4.20% | Reiterated | Strong Performance and Strategic Initiatives Drive Domino's Pizza Buy Rating | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $62 | ― | 10.90% | Downgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $12→$10.5 | ― | 10.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $47→$48.5 | ― | 6.40% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $160→$177 | ― | 2.10% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $252→$256 | ― | 2.10% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $60→$53 | ― | 12.20% | Reiterated | ||||
 | Eplus | BUY | ― | -3.70% | Reiterated | ePlus Positioned for Growth: Strong Recovery and AI-Driven Opportunities | |||
 | Pliant Therapeutics | SELL | ― | -11.30% | Downgraded | Pliant Therapeutics (PLRX) was downgraded to a Sell Rating at J.P. Morgan | |||
| Allogene Therapeutics | SELL | ― | -11.30% | Downgraded | Allogene Therapeutics (ALLO) was downgraded to a Sell Rating at J.P. Morgan | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $360→$350 | ― | 12.20% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $350→$330 | ― | 5.90% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $130→$180 | ― | 16.00% | Upgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $64→$59 | ― | 14.60% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $13→$12 | ― | 12.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD | ― | 4.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $420→$400 | ― | 12.20% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $4 | ― | 1.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $125 | ― | 14.90% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $250 | ― | 23.50% | Reiterated | ||||
 | GeoVax Labs | BUY $14 | ― | -17.80% | Reiterated | Roth MKM Sticks to Their Buy Rating for GeoVax Labs (GOVX) | |||
 | Westlake Corporation | BUY $92→$87 | ― | -3.90% | Reiterated | Westlake price target lowered to $87 from $92 at RBC Capital | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $102→$80 | ― | 9.80% | Reiterated | ||||
| Eastman Chemical | BUY $74→$71 | ― | -3.90% | Reiterated | Eastman Chemical price target lowered to $71 from $74 at RBC Capital | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $75→$60 | ― | 9.80% | Reiterated | ||||
| LyondellBasell | HOLD $54→$50 | ― | -3.90% | Reiterated | LyondellBasell price target lowered to $50 from $54 at RBC Capital | |||
| Celanese | HOLD $45→$43 | ― | -3.90% | Reiterated | Celanese price target lowered to $43 from $45 at RBC Capital | |||
| Olin | HOLD $23→$26 | ― | -3.90% | Reiterated | Olin price target raised to $26 from $23 at RBC Capital | |||
| Dow Inc | HOLD $26→$24 | ― | -3.90% | Reiterated | Dow Inc. price target lowered to $24 from $26 at RBC Capital | |||
| Chemours Company | BUY $15→$19 | ― | -3.90% | Reiterated | Chemours price target raised to $19 from $15 at RBC Capital |
Rows:
